DELEE's Seed Round

DELEE raised a round of funding on March 21, 2017. Investors include Y Combinator.

DELEE is developing a blood test device able to isolate tumor cells. The patent-pending device aims to personalize cancer treatments based on a new approach.…

Articles about DELEE's Seed Round: